Krairittichai, UdomSupaporn, ThanomAimpun, PoteWangsiripaisan, AdisornChaiprasert, AmnartSakulsaengprapha, AmpornChittinandana, AnutraThanachartwet, WipaPalasawatdhi, ValaiSrangsomwong, Soysaang2009-05-272009-05-272006-08-19Krairittichai U, Supaporn T, Aimpun P, Wangsiripaisan A, Chaiprasert A, Sakulsaengprapha A, Chittinandana A, Thanachartwet W, Palasawatdhi V, Srangsomwong S. Anemia and survival in Thai hemodialysis patients: evidence from national registry data. Journal of the Medical Association of Thailand. 2006 Aug; 89 Suppl 2(): S242-7http://imsear.searo.who.int/handle/123456789/44004Chotmaihet Thangphaet.BACKGROUND: Anemia is a major contributor to morbidity and mortality in chronic dialysis patients. The K/DOQI guideline recommends the target hemoglobin of 11-12 g/dl (hematocrit of 33-36%). However the appropriate hematocrit level for Thai hemodialysis patients has been controversial. OBJECTIVE: To investigate the influence of anemia on mortality in Thai chronic hemodialysis patients who initiated their dialysis from 1999 through 2003. MATERIAL AND METHOD: The data from the Thailand Renal Replacement Therapy Registry who has conducted an annual report of chronic dialysis patients throughout Thailand since 1997 was used. Data of twice- and thrice-weekly hemodialysis patients who had recorded hematocrit from 1999 through 2003 were processed and confirmed before final analysis. Records of 3,211 hemodialysis patients from 301 centers were included. RESULT: The original kidney diseases were diabetes mellitus (31.5%) and hypertension (20.9%). Most patients received twice-weekly hemodialysis (86.3%). The mean hematocrit was 29.3 +/- 5.5%. Most patients (72.8%) had hematocrits of less than 33%. Kaplan-Meier analysis showed patients with hematocrit of ?33% or more had better survival than patients with hematocrits of less than 33% (p <0.01). Patients with hematocrits of less than 27, 27-29.9, 30-32.9 and 36% or more had mortality risks of 1.90 (95% CI: 1.31-2.76, p <0.01), 2.10 (95% CI: 1.42-3.09, p <0.01), 1.74 (95% CI: 1.18-2.56, p <0.01) and 1.174 (95% CI: 0.73-1.90, p = 0.51) respectively, compared to those with hematocrit of 33-35.9%. CONCLUSION: The best survival can be achieved in Thai patients with hematocrits of at least 33%.engAnemia --etiologyFemaleHematocrit --standardsHumansKidney Failure, Chronic --complicationsLongitudinal StudiesMaleMiddle AgedProportional Hazards ModelsRegistriesRenal DialysisRetrospective StudiesSurvival RateThailandAnemia and survival in Thai hemodialysis patients: evidence from national registry data.Journal Article